-
Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two-year follow-up of the observational, prospective, controlled, and multicenter ERACI IV registryHaiek C, Fernández-Pereira C, Rodriguez AE et al. -
Management of left main disease: an updateFajadet J, Capodanno D, Stone GW.
-
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-studyKawamoto H, Chieffo A, Colombo A et al.
-
Successful bailout stenting strategy against lethal coronary dissection involving left main bifurcationKubota H, Nomura T, Hori Y et al.
-
Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL TrialCollet C, Stone GW, Serruys PW et al.
-
Quality of Life after Everolimus-Eluting Stents or Bypass Surgery for Treatment of Left Main DiseaseSJ. Baron, K Chinnakondepalli, EA. Magnuson et al.
-
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main and Multivessel Coronary Artery Disease: Do We Have the Evidence?Gersh BJ, Stone GW, Bhatt DL et al.
-
Two-year outcomes following unprotected left main stenting with first vs new-generation drug-eluting stents: the FINE registry. EuroIntervention.Buchanan GL, Chieffo A, Colombo A et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
